References
- P. M. Peloso, Strategies and practice for the use of nonsteroidal anti-inflammatory drugs, Scan. J. Rheumatol. 25 (1996) 29-48.
- A. Figueras, D. Capella, J. M. Castel and J. R. Laporte, Spontaneous reporting of adverse drug reactions to nonsteroidal anti-inflammatory drugs, Eur. J. Clin. Pharmacol. 47 (1994) 297-303; DOI: 10.1007/BF00191158.
- L. M. Lichtenberger, Z. M. Wang, J. J. Romero, C. Ulloa, J. C. Perez, M. N. Giraud and J. C. Barreto, Non steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: Insight into the mechanism and reversal of NSAID-induced gastrointestinal injury, Nature Med. 11 (1995) 154-158; DOI: 10.1038/nm0295-154.
- P. J. Goddard, Y. J. Kao and L. M. Lichtenberger, Luminal surface hydrophobicity of canine gastric mucosa is dependent on a surface mucous gel, Gastroenterology 98 (1990) 361-370.
- L. M. Lichtenberger, L. A. Graziani, E. J. Dial, B. D. Butter and B. A. Hills, Role of surface-active phospholipids in gastric cytoprotection, Science 219 (1983) 1327-1329; DOI: 10.1126/science.6828 859.
- L. M. Lichtenberger, C. Ulloa, J. J. Romero, A. L. Vanous, J. J. Romero, E. J. Dial, P. A. Illich and E. T. Walters, Zwitterionic phospholipids enhance aspirin's therapeutic activity, as demonstrated in rodent model systems, J. Pharmacol. Exp. Ther. 277 (1996) 1221-1227.
- S. S. Biju, S. Talegaonkar, P. R. Mishra and R. K. Khar, Vesicular systems: an overview, Indian J. Pharm. Sci. 68 (2006) 141-153.
- United States Pharmacopoeia 23, National Formulary 18, USP Convention, Rockville (MD) 1999, pp. 1791-1792.
- H. Maswadeh, A. Abdulhalim and C. Demetzos, Improvement of encapsulation efficiency of diclofenac sodium into uncoated and chitosan-coated liposomes, Indian J. Pharm. Sci. 66 (2004) 607-612.
- L. M. Lichtenberger, C. Ulloa, J. J. Romero, A. L. Vanous, P. A. Illich and E. J. Dial, Nonsteroidal anti-inflammatory drug and phospholipid prodrugs: Combination therapy with antisecretory agents in rats, Gastroenterology 111 (1996) 990-995; DOI: 10.1016/S0016-5085(96)70066-5.
- M. Semalty, A. Semalty, D. Singh, T. Chamoli and M. S. M. Rawat, Effect of purity of phospholipids in improving bioavailability performance of aspirin-phospholipid complex, National Convention of Chemistry Teachers (NCCT) Annual Conference and Convention, Nov 8-9 2008, Srinagar (Garhwal), India, Book of Abstracts, Indian Association of Chemistry Teachers, Srinagar 2008, p. 72.
- X. Yanyu, S. Yunmei, C. Zhipeng and P. Quineng, The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats, Int. J. Pharm. 307 (2006) 77-82; DOI: 10.1016/j.ijpharm.2005.10.001.
- Y. Li, D. J. Yang, S. L. Chen, S. B. Chen and A. S. C. Chan, Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods, Pharm. Res. 25 (2007) 563-577; DOI: 10.1007/s11095-007-9418-x.
- K. Maiti, K. Mukherjee, A. Gantait, B. P. Saha and P. K. Mukherjee, Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats, Int. J. Pharm. 330 (2007) 155-163; DOI: 10.1016/j.ijpharm.2006.09.025.
- D. J. Jarmer, C. S. Lengsfeld, K. S. Anseth and T. W. Randolph, Supercritical fluid crystallization of griseofulvin: Crystal habit modification with a selective growth inhibitor, J. Pharm. Sci. 94 (2005) 2688-2702; DOI: 10.1002/jps.20463.